z-logo
Premium
Evidence for a non‐adrenoceptor, imidazoline‐mediated contractile response to oxymetazoline in the porcine isolated rectal artery
Author(s) -
Minyan Wang,
Dunn W R,
Blaylock N A,
Chan S L F,
Wilson V G
Publication year - 2001
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703949
Subject(s) - oxymetazoline , imidazoline receptor , prazosin , phenoxybenzamine , idazoxan , endocrinology , medicine , chemistry , vasoconstriction , agonist , pharmacology , antagonist , receptor , propranolol
Imidazoline derivatives are known to elicit responses through both α 2 ‐adrenoceptor and non‐adrenoceptor, imidazoline sites, though as yet there are no examples of the latter on vascular smooth muscle. In the presence of 0.3 μ M prazosin, neither UK‐14304 (0.01 – 3 μ M ) nor oxymetazoline (0.01 – 30 μ M ) caused a significant contraction of the porcine isolated rectal artery, a preparation with a low density of α 2 ‐adrenoceptors. In the presence of a combination of U46619 and forskolin, however, both agonists produced concentration‐dependent contractions. Pretreatment with phenoxybenzamine (3 μ M ) abolished responses to UK‐14304, but left those elicited by oxymetazoline largely unaffected. The putative I 3 imidazoline antagonist 2‐(2,3 dihydro‐2‐benzofuranyl)‐2‐imidazole (KU‐14R, 10 μ M ) caused a 6 fold rightward displacement of the phenoxybenzamine‐insensitive concentration – response curve to oxymetazoline. Our data indicates that non‐adrenoceptor, imidazoline sites, pharmacologically similar to the I 3 imidazoline site on islet cells, mediate vasoconstriction in the porcine isolated rectal artery. British Journal of Pharmacology (2001) 132 , 1359–1363; doi: 10.1038/sj.bjp.0703949

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom